Deutsche Bank AG Takes Position in The Clorox Company $CLX

Deutsche Bank AG purchased a new stake in shares of The Clorox Company (NYSE:CLXFree Report) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 717,442 shares of the company’s stock, valued at approximately $68,473,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares in the last quarter. Woodline Partners LP grew its stake in shares of Clorox by 253.7% during the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after acquiring an additional 7,465 shares in the last quarter. Baird Financial Group Inc. increased its position in shares of Clorox by 1.7% during the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after acquiring an additional 424 shares during the last quarter. Jump Financial LLC increased its position in shares of Clorox by 173.5% during the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after acquiring an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia lifted its stake in shares of Clorox by 26.2% in the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after acquiring an additional 3,352 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.8%

Shares of Clorox stock opened at $106.00 on Friday. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The firm has a market cap of $12.82 billion, a P/E ratio of 21.99, a P/E/G ratio of 3.23 and a beta of 0.54. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $128.90. The business has a 50-day moving average price of $98.77 and a 200 day moving average price of $103.11.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. During the same quarter in the prior year, the firm posted $2.87 earnings per share. Clorox’s revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, sell-side analysts forecast that The Clorox Company will post 5.8 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 4.7%. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date is Wednesday, August 12th. Clorox’s dividend payout ratio (DPR) is 103.73%.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft set a $98.00 price target on Clorox in a report on Tuesday, August 4th. JPMorgan Chase & Co. lifted their price objective on Clorox from $92.00 to $95.00 and gave the stock an “underweight” rating in a report on Tuesday, August 4th. Morgan Stanley cut their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Finally, UBS Group raised their price target on shares of Clorox from $100.00 to $105.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $102.40.

Check Out Our Latest Stock Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.